Загрузка видео...

Не удалось загрузить видео

На главную

🔥Ivermectin is being studied for anticancer activity — but natural compounds like quercetin, berberine, EGCG, curcumin, and artemisinin target similar pathways. • Ivermectin blocks growth pathways like Akt/mTOR and WNT, induces apoptosis, and starves tumors of blood supply. • But natural compounds overlap: • Quercetin in onions/apples blocks Akt...

JoeTippen's profile picture

Joe Tippens

86,212 subscribers

27,524 просмотров • 8 месяцев назад •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

🔥CANCER STEM CELLS: THE ROOT OF RESISTANCE Here are 10 foods proven in studies to help suppress or kill cancer stem cells: 🥇 Curcumin – From turmeric. Blocks self-renewal in breast and colon CSCs. 🥦 Sulforaphane – In broccoli sprouts. Eliminates tumor-initiating cells. 🍵 EGCG – Found in green tea. Shuts down Nanog and Oct4 stemness pathways. 🧅 Quercetin – In onions and capers. Reduces CSC markers like CD44. 🍇 Resveratrol – From grapes. Induces apoptosis in brain and colon CSCs. 🌿 Apigenin – In parsley and chamomile. Inhibits CSC migration and survival. 🫐 Pterostilbene – In blueberries. Disrupts mammary CSC formation. 🌱 Berberine – From herbs like goldenseal. Slows ovarian and liver CSC growth. 🥢 Genistein – In fermented soy. Targets Hedgehog + Notch CSC signaling. 🌸 Honokiol – From magnolia bark. Disarms glioblastoma stem cells. These foods target the real threat behind recurrence: cancer stem cells (CSCs). 📚 Studies confirm they inhibit stemness pathways like Wnt, Notch, Hedgehog, and VEGF, helping restore metabolic balance and starve resistance. ✅ Comment “PROTOCOL” for my full anti-cancer food + terrain guide ✅ Comment “EMAIL” for detox and stem cell targeting tips ✅ Comment “CONSULT” to work with me directly 📩 Check your messages for the links. If you don’t remove the root, the weed grows back. These foods help your body do what chemo can’t. ⚠️ DISCLAIMER: This content is for educational purposes only and is not intended to diagnose, treat, or cure any disease. Always consult your provider before starting any new protocols.
1:04

🔥CANCER STEM CELLS: THE ROOT OF RESISTANCE Here are 10 foods proven in studies to help suppress or kill cancer stem cells: 🥇 Curcumin – From turmeric. Blocks self-renewal in breast and colon CSCs. 🥦 Sulforaphane – In broccoli sprouts. Eliminates tumor-initiating cells. 🍵 EGCG – Found in green tea. Shuts down Nanog and Oct4 stemness pathways. 🧅 Quercetin – In onions and capers. Reduces CSC markers like CD44. 🍇 Resveratrol – From grapes. Induces apoptosis in brain and colon CSCs. 🌿 Apigenin – In parsley and chamomile. Inhibits CSC migration and survival. 🫐 Pterostilbene – In blueberries. Disrupts mammary CSC formation. 🌱 Berberine – From herbs like goldenseal. Slows ovarian and liver CSC growth. 🥢 Genistein – In fermented soy. Targets Hedgehog + Notch CSC signaling. 🌸 Honokiol – From magnolia bark. Disarms glioblastoma stem cells. These foods target the real threat behind recurrence: cancer stem cells (CSCs). 📚 Studies confirm they inhibit stemness pathways like Wnt, Notch, Hedgehog, and VEGF, helping restore metabolic balance and starve resistance. ✅ Comment “PROTOCOL” for my full anti-cancer food + terrain guide ✅ Comment “EMAIL” for detox and stem cell targeting tips ✅ Comment “CONSULT” to work with me directly 📩 Check your messages for the links. If you don’t remove the root, the weed grows back. These foods help your body do what chemo can’t. ⚠️ DISCLAIMER: This content is for educational purposes only and is not intended to diagnose, treat, or cure any disease. Always consult your provider before starting any new protocols.

Joe Tippens

13,813 просмотров • 1 месяц назад

⚔️ BLOCKING GLUTAMINE NATURALLY When cancer cells can’t get glucose, they often switch to glutamine, a key amino acid involved in cell growth and repair. 🍄 Mistletoe—immune-regulating and disrupts glutamine-dependent cancer growth 🌿 Curcumin—shown to interfere with glutamine metabolism in aggressive tumors 🍵 Green tea (EGCG)—again, powerful here as well 🌿 Berberine—reduces expression of glutamine transporters 🧠 Honokiol (from magnolia bark)—neuroprotective and suppresses glutamine usage 🍄 Turkey tail mushroom—modulates immune response and may slow glutamine-driven cell replication 🥬 Fermented vegetables—rich in butyrate, which opposes glutamine-fueled inflammation 🥥 Coconut oil—encourages ketone metabolism over glutamine ✅ Suggested Stack: • AM: Honokiol + green tea • PM: Curcumin + mistletoe extract (consult with a practitioner) • Daily: Coconut oil for brain fuel + fermented foods for terrain healing 🧬 Avoid excess animal protein during active treatment—glutamine is abundant in meat. ✅ STUDIES: • Cell Metabolism (2013): Glutamine metabolism is essential for tumor growth in low-glucose environments. • Molecules (2020): Curcumin inhibits glutaminase, the enzyme that converts glutamine to fuel in cancer cells. • Frontiers in Oncology (2022): Mistletoe extract shown to downregulate glutamine pathways in colorectal cancer cells. • Oncotarget (2015): Honokiol targets mitochondrial glutamine metabolism in glioma models. 🔥Cancer adapts fast. But so can you. Block the second fuel… And give your body the upper hand it was designed to have. -Dr Pete Sulack
1:26

⚔️ BLOCKING GLUTAMINE NATURALLY When cancer cells can’t get glucose, they often switch to glutamine, a key amino acid involved in cell growth and repair. 🍄 Mistletoe—immune-regulating and disrupts glutamine-dependent cancer growth 🌿 Curcumin—shown to interfere with glutamine metabolism in aggressive tumors 🍵 Green tea (EGCG)—again, powerful here as well 🌿 Berberine—reduces expression of glutamine transporters 🧠 Honokiol (from magnolia bark)—neuroprotective and suppresses glutamine usage 🍄 Turkey tail mushroom—modulates immune response and may slow glutamine-driven cell replication 🥬 Fermented vegetables—rich in butyrate, which opposes glutamine-fueled inflammation 🥥 Coconut oil—encourages ketone metabolism over glutamine ✅ Suggested Stack: • AM: Honokiol + green tea • PM: Curcumin + mistletoe extract (consult with a practitioner) • Daily: Coconut oil for brain fuel + fermented foods for terrain healing 🧬 Avoid excess animal protein during active treatment—glutamine is abundant in meat. ✅ STUDIES: • Cell Metabolism (2013): Glutamine metabolism is essential for tumor growth in low-glucose environments. • Molecules (2020): Curcumin inhibits glutaminase, the enzyme that converts glutamine to fuel in cancer cells. • Frontiers in Oncology (2022): Mistletoe extract shown to downregulate glutamine pathways in colorectal cancer cells. • Oncotarget (2015): Honokiol targets mitochondrial glutamine metabolism in glioma models. 🔥Cancer adapts fast. But so can you. Block the second fuel… And give your body the upper hand it was designed to have. -Dr Pete Sulack

Cleanse Parasites .com 🧹🪱 Herbal Cleanse Co.

137,799 просмотров • 1 год назад

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.
1:37

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Commentary | Global Ivermectin Research Hub

25,180 просмотров • 1 месяц назад

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.
1:37

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Joe Tippens

25,626 просмотров • 1 месяц назад

Most people don’t realize… Cancer can’t grow beyond the size of a pinhead without creating its own blood supply. That process is called angiogenesis — when tumors hijack your body’s blood vessel system to feed themselves. 🩸 But here’s the good news 👇 You can turn off angiogenesis naturally by eating foods that block VEGF (the growth signal tumors send out for new blood vessels). 🍵 Green tea 🥦 Broccoli & kale 🍓 Berries 🧄 Garlic 🌶️ Turmeric + black pepper combo 🍅 Tomatoes & onions These foods contain compounds like sulforaphane, quercetin, curcumin, and lycopene — nature’s own angiogenesis inhibitors that help starve tumors at the root. You don’t need extreme diets or fear… You just need knowledge and consistency. 💚 This is why we say: “Starve cancer. Nourish your cells.” #DivineJuicery #StarveCancer #AntiAngiogenesis #CancerNutrition #FunctionalFoods #HealingInABottle #Autophagy #CellularHealth #MicronutrientMedicine
2:00

Most people don’t realize… Cancer can’t grow beyond the size of a pinhead without creating its own blood supply. That process is called angiogenesis — when tumors hijack your body’s blood vessel system to feed themselves. 🩸 But here’s the good news 👇 You can turn off angiogenesis naturally by eating foods that block VEGF (the growth signal tumors send out for new blood vessels). 🍵 Green tea 🥦 Broccoli & kale 🍓 Berries 🧄 Garlic 🌶️ Turmeric + black pepper combo 🍅 Tomatoes & onions These foods contain compounds like sulforaphane, quercetin, curcumin, and lycopene — nature’s own angiogenesis inhibitors that help starve tumors at the root. You don’t need extreme diets or fear… You just need knowledge and consistency. 💚 This is why we say: “Starve cancer. Nourish your cells.” #DivineJuicery #StarveCancer #AntiAngiogenesis #CancerNutrition #FunctionalFoods #HealingInABottle #Autophagy #CellularHealth #MicronutrientMedicine

!Nspirenaire〽️

276,481 просмотров • 7 месяцев назад

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.
0:59

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.

Joe Tippens

10,621 просмотров • 2 месяцев назад

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCure
3:28

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCure

PharmacyinUSA

15,268 просмотров • 2 месяцев назад

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.
9:41

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 просмотров • 1 год назад

IVERMECTIN and LACTOFERRIN TESTIMONIAL - Oscar Nacu (Philippines, Aug.2022) IVERMECTIN and LACTOFERRIN Synergy Both compounds exhibit anticancer properties through overlapping pathways, such as inducing apoptosis (programmed cell death), modulating immune responses, and disrupting cancer cell metabolism and proliferation Lactoferrin can enhance Ivermectin’s effects by amplifying immune activation and oxidative stress, which may make cancer cells more vulnerable to IVM’s metabolic disruptions and apoptotic induction 1. Enhanced Apoptosis and Cell Death Pathways Individual Mechanisms: Lactoferrin induces apoptosis in cancer cells by damaging the cytoskeleton, activating caspases (e.g., caspase-3), upregulating pro-apoptotic proteins like BAX/BAK, and causing cell cycle arrest (e.g., G1/S or G2/M phases). It also reduces cell migration and invasion by reversing epithelial-mesenchymal transition (EMT), downregulating proteins like vimentin, SNAIL, and TWIST. Ivermectin promotes apoptosis via mitochondrial dysfunction, increasing reactive oxygen species (ROS), elevating the Bax/Bcl-2 ratio, and activating caspases 9/3. It also inhibits proliferation through cell cycle arrest and targets cancer stem cells. How They Work Together: Lactoferrin’s ability to induce oxidative stress and DNA damage complements Ivermectin’s ROS elevation and mitochondrial inhibition. This dual assault on cellular energy and redox balance could lower the threshold for apoptosis, making cancer cells more susceptible to Ivermectin’s effects 2. Immune Modulation and Tumor Microenvironment Remodeling Individual Mechanisms: Lactoferrin stimulates the adaptive immune response, reshapes the tumor microenvironment by downregulating pro-inflammatory cytokines (e.g., IL-6), and inhibits cancer progression through immunostimulatory effects. It also protects against iron disorders, depriving iron-dependent cancer cells while modulating immunity. Ivermectin has immunomodulatory properties, converting “cold” tumors (immune-deserted) to “hot” ones (immune-infiltrated) by inducing immunogenic cell death (ICD), releasing ATP and HMGB1, depleting immunosuppressive cells (e.g., MDSCs and Tregs), and enhancing CD8+ T-cell infiltration. How They Work Together: Lactoferrin’s cytokine downregulation and immune stimulation could amplify Ivermectin’s ICD and T-cell recruitment, creating a more hostile environment for cancer cells. For example, Ivermectin’s ability to boost Teff/Treg ratios pairs well with Lactoferrin’s anti-inflammatory effects, potentially enhancing overall antitumor immunity. 3. Disruption of Cancer Cell Metabolism and Proliferation Individual Mechanisms: Lactoferrin inhibits oncogenic pathways like PI3K/AKT/mTOR and Wnt, reducing proliferation and angiogenesis (e.g., downregulating VEGFR2). Ivermectin interferes with metabolic pathways, downregulating TCA cycle enzymes (e.g., IDH2, DLST), inhibiting glycolysis/oxidative phosphorylation, and limiting glutamine-derived intermediates for biosynthesis. How They Work Together: Lactoferrin’s iron sequestration starves cancer cells of essential metals for metabolic enzymes, synergizing with Ivermectin’s TCA cycle disruption to exacerbate energy shortages and biosynthetic limitations. This is particularly relevant in “glutamine-addicted” cancers like ovarian or prostate, where combined metabolic stress promotes apoptosis. (Podcast: Dr.Allan Landrito, Dr.Mahin Khatami, Dr.Shankara Chetty" === I have the world's largest Ivermectin Cancer Clientele, 7900 strong! Joseph A. Ladapo, MD, PhD
6:19

IVERMECTIN and LACTOFERRIN TESTIMONIAL - Oscar Nacu (Philippines, Aug.2022) IVERMECTIN and LACTOFERRIN Synergy Both compounds exhibit anticancer properties through overlapping pathways, such as inducing apoptosis (programmed cell death), modulating immune responses, and disrupting cancer cell metabolism and proliferation Lactoferrin can enhance Ivermectin’s effects by amplifying immune activation and oxidative stress, which may make cancer cells more vulnerable to IVM’s metabolic disruptions and apoptotic induction 1. Enhanced Apoptosis and Cell Death Pathways Individual Mechanisms: Lactoferrin induces apoptosis in cancer cells by damaging the cytoskeleton, activating caspases (e.g., caspase-3), upregulating pro-apoptotic proteins like BAX/BAK, and causing cell cycle arrest (e.g., G1/S or G2/M phases). It also reduces cell migration and invasion by reversing epithelial-mesenchymal transition (EMT), downregulating proteins like vimentin, SNAIL, and TWIST. Ivermectin promotes apoptosis via mitochondrial dysfunction, increasing reactive oxygen species (ROS), elevating the Bax/Bcl-2 ratio, and activating caspases 9/3. It also inhibits proliferation through cell cycle arrest and targets cancer stem cells. How They Work Together: Lactoferrin’s ability to induce oxidative stress and DNA damage complements Ivermectin’s ROS elevation and mitochondrial inhibition. This dual assault on cellular energy and redox balance could lower the threshold for apoptosis, making cancer cells more susceptible to Ivermectin’s effects 2. Immune Modulation and Tumor Microenvironment Remodeling Individual Mechanisms: Lactoferrin stimulates the adaptive immune response, reshapes the tumor microenvironment by downregulating pro-inflammatory cytokines (e.g., IL-6), and inhibits cancer progression through immunostimulatory effects. It also protects against iron disorders, depriving iron-dependent cancer cells while modulating immunity. Ivermectin has immunomodulatory properties, converting “cold” tumors (immune-deserted) to “hot” ones (immune-infiltrated) by inducing immunogenic cell death (ICD), releasing ATP and HMGB1, depleting immunosuppressive cells (e.g., MDSCs and Tregs), and enhancing CD8+ T-cell infiltration. How They Work Together: Lactoferrin’s cytokine downregulation and immune stimulation could amplify Ivermectin’s ICD and T-cell recruitment, creating a more hostile environment for cancer cells. For example, Ivermectin’s ability to boost Teff/Treg ratios pairs well with Lactoferrin’s anti-inflammatory effects, potentially enhancing overall antitumor immunity. 3. Disruption of Cancer Cell Metabolism and Proliferation Individual Mechanisms: Lactoferrin inhibits oncogenic pathways like PI3K/AKT/mTOR and Wnt, reducing proliferation and angiogenesis (e.g., downregulating VEGFR2). Ivermectin interferes with metabolic pathways, downregulating TCA cycle enzymes (e.g., IDH2, DLST), inhibiting glycolysis/oxidative phosphorylation, and limiting glutamine-derived intermediates for biosynthesis. How They Work Together: Lactoferrin’s iron sequestration starves cancer cells of essential metals for metabolic enzymes, synergizing with Ivermectin’s TCA cycle disruption to exacerbate energy shortages and biosynthetic limitations. This is particularly relevant in “glutamine-addicted” cancers like ovarian or prostate, where combined metabolic stress promotes apoptosis. (Podcast: Dr.Allan Landrito, Dr.Mahin Khatami, Dr.Shankara Chetty" === I have the world's largest Ivermectin Cancer Clientele, 7900 strong! Joseph A. Ladapo, MD, PhD

Dr. William Makis MD

48,226 просмотров • 7 месяцев назад

Curing CANCER, PARKINSONS, MULTIPLE SCLEROSIS, & most every other disease is a 2-fold process. Taking IVERMECTIN & FENBENDAZOLE kills the PARASITES that are causing these diseases. But MANUFACTURED FOOD, FAST FOOD, REFINED SUGAR, ENRICHED-BLEACHED FLOUR (MANUFACTURED BREAD…) - plus BIG PHARMA DRUGS & VACCINES - all of this needs to be removed stopped. You can kill the worms & flukes & other parasites easily with the above, but it dies not solve everything without YOU making changes too. Have you read about how to do the juicing for two meals day that I post often? Let me know & I will Post it again. DR. LEE MERRITT - CANCER IS REALLY PARASITES! MULTIPLE SCLEROSIS is PARASITES in SPINAL CORD & BRAIN. IT'S ALL PARASITES - ALMOST ALL DISEASES - CANCER - LYME - LEUKEMIA ETC. Fenbendazole Enhancing Anti-Tumor Effect: A Case Series I STILL TAKE FENBENDAZOLE 3 DAYS ON, 4 DAYS OFF, 1gr pkg. 1 GRAM = 0.3527 ounce = A PEA-SIZE DOSE of HORSE PASTE! This is extremely safe to take every day, no days off. No elevated liver enzymes with this protocol. Save your life and don’t let your doctors frighten you that this will harm your liver, It’s just not true! God bless, and good luck.” ~Joe Clark JOE TIPPENS PROTOCOL - FENBENDAZOLE - BROAD SPECTRUM PARASITES TREATMENT: FENBENDAZOLE CBD OIL BERBERINE QUERCETIN TURMERIC NATURAL BERBERINE: BARBERRY (small red berry) GOLDENSEAL OREGON GRAPE PHELLODENDRON CHINESE GOLDTHREAD TREE TURMERIC (INDIAN BARBERRY) PRICKLY POPPY YELLOWROOT Berberine regulates blood sugar, improves insulin sensitivity, and supports fat metabolism. Consume berberine-rich plants such as barberry, goldenseal, Oregon grape, and Chinese goldthread. Best Natural Sources of QUERCETIN: Onion Nettle Oak Pomegranate Sea Buckthorn Chamomile Black Grapes Blackberries Oregano Turmeric = curcumin? Turmeric is the spice that gives curry its yellow color. It has been used in India for thousands of years as both a spice and medicinal herb. Turmeric contains compounds with medicinal properties These compounds are called curcuminoids. The most important one is CURCUMIN, which is the main active ingredient in turmeric. THE PARASITE PROBLEM Relationship between parasite infections / infestations and brain disease, mental illnesses, suicidal thoughts and attempts, sexual deviancies, and other problems.. PART 1 ( PART 2 ( 🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼 CANCER IS CAUSED BY PARASITES VIDEO PROOF
11:40

Curing CANCER, PARKINSONS, MULTIPLE SCLEROSIS, & most every other disease is a 2-fold process. Taking IVERMECTIN & FENBENDAZOLE kills the PARASITES that are causing these diseases. But MANUFACTURED FOOD, FAST FOOD, REFINED SUGAR, ENRICHED-BLEACHED FLOUR (MANUFACTURED BREAD…) - plus BIG PHARMA DRUGS & VACCINES - all of this needs to be removed stopped. You can kill the worms & flukes & other parasites easily with the above, but it dies not solve everything without YOU making changes too. Have you read about how to do the juicing for two meals day that I post often? Let me know & I will Post it again. DR. LEE MERRITT - CANCER IS REALLY PARASITES! MULTIPLE SCLEROSIS is PARASITES in SPINAL CORD & BRAIN. IT'S ALL PARASITES - ALMOST ALL DISEASES - CANCER - LYME - LEUKEMIA ETC. Fenbendazole Enhancing Anti-Tumor Effect: A Case Series I STILL TAKE FENBENDAZOLE 3 DAYS ON, 4 DAYS OFF, 1gr pkg. 1 GRAM = 0.3527 ounce = A PEA-SIZE DOSE of HORSE PASTE! This is extremely safe to take every day, no days off. No elevated liver enzymes with this protocol. Save your life and don’t let your doctors frighten you that this will harm your liver, It’s just not true! God bless, and good luck.” ~Joe Clark JOE TIPPENS PROTOCOL - FENBENDAZOLE - BROAD SPECTRUM PARASITES TREATMENT: FENBENDAZOLE CBD OIL BERBERINE QUERCETIN TURMERIC NATURAL BERBERINE: BARBERRY (small red berry) GOLDENSEAL OREGON GRAPE PHELLODENDRON CHINESE GOLDTHREAD TREE TURMERIC (INDIAN BARBERRY) PRICKLY POPPY YELLOWROOT Berberine regulates blood sugar, improves insulin sensitivity, and supports fat metabolism. Consume berberine-rich plants such as barberry, goldenseal, Oregon grape, and Chinese goldthread. Best Natural Sources of QUERCETIN: Onion Nettle Oak Pomegranate Sea Buckthorn Chamomile Black Grapes Blackberries Oregano Turmeric = curcumin? Turmeric is the spice that gives curry its yellow color. It has been used in India for thousands of years as both a spice and medicinal herb. Turmeric contains compounds with medicinal properties These compounds are called curcuminoids. The most important one is CURCUMIN, which is the main active ingredient in turmeric. THE PARASITE PROBLEM Relationship between parasite infections / infestations and brain disease, mental illnesses, suicidal thoughts and attempts, sexual deviancies, and other problems.. PART 1 ( PART 2 ( 🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼 CANCER IS CAUSED BY PARASITES VIDEO PROOF

skymeds store | Online Ivermectin Pharmacy

18,924 просмотров • 1 год назад

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds
3:32

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 просмотров • 2 месяцев назад

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure
3:49

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Dr. Zakaria MD

46,717 просмотров • 1 месяц назад

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD
4:38

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD

RXMEDS.STORE

17,227 просмотров • 13 дней назад

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.
3:43

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

The Vigilant Fox 🦊

532,851 просмотров • 2 лет назад

REPORT: A declassified CIA document suggests a potential cure for cancer may have been hidden from the public for more than 60 years. The discovery is fueling a disturbing question: if this research showed promise in the early 1950s, why did it remain locked away in intelligence archives for decades? The document, written in February 1951 and later declassified in 2014, summarizes a Soviet scientific paper examining striking biochemical similarities between parasitic worms and cancerous tumors. Researchers reported that both thrived under similar metabolic conditions, surviving in low-oxygen environments and storing large reserves of glycogen. The report also described experiments showing certain anti-parasitic compounds appeared to affect tumors. One drug, Myracyl D, already used to treat bilharzia parasites, reportedly showed activity against malignant growths as well. The findings didn’t claim cancer is caused by parasites. But they raised a provocative possibility: drugs developed to kill parasites might also disrupt tumor growth. Today, some physicians are revisiting that idea. Dr. William Makis, who treats cancer patients with repurposed medications such as ivermectin and related compounds, says he has worked with thousands of patients using these experimental treatment protocols. Makis believes the potential of these drugs has been underestimated for years. “Cancer is no longer a death sentence.” So why did research like this sit in the shadows for so long? Don't miss ZeeeMediaOfficial's report: 👇
12:42

REPORT: A declassified CIA document suggests a potential cure for cancer may have been hidden from the public for more than 60 years. The discovery is fueling a disturbing question: if this research showed promise in the early 1950s, why did it remain locked away in intelligence archives for decades? The document, written in February 1951 and later declassified in 2014, summarizes a Soviet scientific paper examining striking biochemical similarities between parasitic worms and cancerous tumors. Researchers reported that both thrived under similar metabolic conditions, surviving in low-oxygen environments and storing large reserves of glycogen. The report also described experiments showing certain anti-parasitic compounds appeared to affect tumors. One drug, Myracyl D, already used to treat bilharzia parasites, reportedly showed activity against malignant growths as well. The findings didn’t claim cancer is caused by parasites. But they raised a provocative possibility: drugs developed to kill parasites might also disrupt tumor growth. Today, some physicians are revisiting that idea. Dr. William Makis, who treats cancer patients with repurposed medications such as ivermectin and related compounds, says he has worked with thousands of patients using these experimental treatment protocols. Makis believes the potential of these drugs has been underestimated for years. “Cancer is no longer a death sentence.” So why did research like this sit in the shadows for so long? Don't miss ZeeeMediaOfficial's report: 👇

The Vigilant Fox 🦊

196,909 просмотров • 5 месяцев назад

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."
1:59

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."

Sense Receptor

228,297 просмотров • 8 месяцев назад

REPORT: The NIH is now funding research into ivermectin as a cancer treatment. Yes, the same drug they mocked as “horse paste” is now being seriously studied—for its ability to kill cancer cells. On February 10, the NIH confirmed it’s funding preclinical trials on ivermectin’s anti-cancer properties. Dr. Anthony Letai, head of the National Cancer Institute, said there’s “enough interest” and “enough reports” to take it seriously. Studies are already underway, with results expected in just a few months. This follows 2024 and 2025 reviews by U.S. scientists showing signs that ivermectin can inhibit tumors. The NIH is now backing that research, pointing to ivermectin’s Nobel Prize-winning legacy and its decades of safe, FDA-approved use in humans. But instead of welcoming a promising, low-cost treatment, the media doubled down. Outlets like MedPage Today rushed to dismiss the story as “right-wing hype,” ignoring the science and smearing anyone who dared to ask questions. Why attack a drug that could save lives—unless the real threat is to their bottom line? If ivermectin works, it won’t just save lives. It’ll shatter the system built to suppress it. 👇
8:32

REPORT: The NIH is now funding research into ivermectin as a cancer treatment. Yes, the same drug they mocked as “horse paste” is now being seriously studied—for its ability to kill cancer cells. On February 10, the NIH confirmed it’s funding preclinical trials on ivermectin’s anti-cancer properties. Dr. Anthony Letai, head of the National Cancer Institute, said there’s “enough interest” and “enough reports” to take it seriously. Studies are already underway, with results expected in just a few months. This follows 2024 and 2025 reviews by U.S. scientists showing signs that ivermectin can inhibit tumors. The NIH is now backing that research, pointing to ivermectin’s Nobel Prize-winning legacy and its decades of safe, FDA-approved use in humans. But instead of welcoming a promising, low-cost treatment, the media doubled down. Outlets like MedPage Today rushed to dismiss the story as “right-wing hype,” ignoring the science and smearing anyone who dared to ask questions. Why attack a drug that could save lives—unless the real threat is to their bottom line? If ivermectin works, it won’t just save lives. It’ll shatter the system built to suppress it. 👇

The Vigilant Fox 🦊

91,190 просмотров • 6 месяцев назад

REPORT: The NIH is now funding research into ivermectin as a cancer treatment. Yes, the same drug they mocked as “horse paste” is now being seriously studied—for its ability to kill cancer cells. On February 10, the NIH confirmed it’s funding preclinical trials on ivermectin’s anti-cancer properties. Dr. Anthony Letai, head of the National Cancer Institute, said there’s “enough interest” and “enough reports” to take it seriously. Studies are already underway, with results expected in just a few months. This follows 2024 and 2025 reviews by U.S. scientists showing signs that ivermectin can inhibit tumors. The NIH is now backing that research, pointing to ivermectin’s Nobel Prize-winning legacy and its decades of safe, FDA-approved use in humans. But instead of welcoming a promising, low-cost treatment, the media doubled down. Outlets like MedPage Today rushed to dismiss the story as “right-wing hype,” ignoring the science and smearing anyone who dared to ask questions. Why attack a drug that could save lives—unless the real threat is to their bottom line? If ivermectin works, it won’t just save lives. It’ll shatter the system built to suppress it.
8:32

REPORT: The NIH is now funding research into ivermectin as a cancer treatment. Yes, the same drug they mocked as “horse paste” is now being seriously studied—for its ability to kill cancer cells. On February 10, the NIH confirmed it’s funding preclinical trials on ivermectin’s anti-cancer properties. Dr. Anthony Letai, head of the National Cancer Institute, said there’s “enough interest” and “enough reports” to take it seriously. Studies are already underway, with results expected in just a few months. This follows 2024 and 2025 reviews by U.S. scientists showing signs that ivermectin can inhibit tumors. The NIH is now backing that research, pointing to ivermectin’s Nobel Prize-winning legacy and its decades of safe, FDA-approved use in humans. But instead of welcoming a promising, low-cost treatment, the media doubled down. Outlets like MedPage Today rushed to dismiss the story as “right-wing hype,” ignoring the science and smearing anyone who dared to ask questions. Why attack a drug that could save lives—unless the real threat is to their bottom line? If ivermectin works, it won’t just save lives. It’ll shatter the system built to suppress it.

Joe Tippens

74,195 просмотров • 5 месяцев назад

🚨 Why Ivermectin Shows So Much Promise Against Cancer (But Almost No Human Trials) Ivermectin doesn’t just have one or two effects on cancer; it has over a dozen different mechanisms of action. Here are some of the key ones: - Kills cancer stem cells (the cells chemotherapy often misses) - Reverses multidrug resistance, making cancer cells more sensitive to chemotherapy again - Acts as a radiosensitizer, helping radiation work better - Inhibits angiogenesis (stops tumors from forming new blood vessels) - Blocks matrix metalloproteinases, which helps prevent cancer from spreading and metastasizing Despite hundreds of preclinical studies showing these effects, there are almost no large human trials. Only small case reports exist (for example, some leukemia patients showing remission). Why? Because Ivermectin has been off-patent since the 1990s. It’s a cheap, generic drug. When there’s no money to be made, tragically, large-scale research rarely happens, especially in oncology. This is the same story with many other repurposed drugs. Promising lab results exist, but without financial incentive, human trials rarely move forward. That’s why so many patients are now doing their own research into these options. If you're exploring Ivermectin or Fenbendazole protocols, many people are choosing clean, pharmaceutical-grade versions from PharmacyinUSA. Save this for reference. #Ivermectin #CancerResearch #RepurposedDrugs #Fenbendazole #CancerStemCells
2:06

🚨 Why Ivermectin Shows So Much Promise Against Cancer (But Almost No Human Trials) Ivermectin doesn’t just have one or two effects on cancer; it has over a dozen different mechanisms of action. Here are some of the key ones: - Kills cancer stem cells (the cells chemotherapy often misses) - Reverses multidrug resistance, making cancer cells more sensitive to chemotherapy again - Acts as a radiosensitizer, helping radiation work better - Inhibits angiogenesis (stops tumors from forming new blood vessels) - Blocks matrix metalloproteinases, which helps prevent cancer from spreading and metastasizing Despite hundreds of preclinical studies showing these effects, there are almost no large human trials. Only small case reports exist (for example, some leukemia patients showing remission). Why? Because Ivermectin has been off-patent since the 1990s. It’s a cheap, generic drug. When there’s no money to be made, tragically, large-scale research rarely happens, especially in oncology. This is the same story with many other repurposed drugs. Promising lab results exist, but without financial incentive, human trials rarely move forward. That’s why so many patients are now doing their own research into these options. If you're exploring Ivermectin or Fenbendazole protocols, many people are choosing clean, pharmaceutical-grade versions from PharmacyinUSA. Save this for reference. #Ivermectin #CancerResearch #RepurposedDrugs #Fenbendazole #CancerStemCells

PharmacyinUSA

12,063 просмотров • 26 дней назад